Interferon alfa-2a

British Journal of Hospital Medicine

Volumn 57, Issue 9, 1997, Pages 436-439

  Williams, C D ^a,b   Linch, D C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT;

CHRONIC MYELOID LEUKEMIA; COST BENEFIT ANALYSIS; HAIRY CELL LEUKEMIA; HEPATITIS B; HEPATITIS C; HUMAN; KAPOSI SARCOMA; KIDNEY TUMOR; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; REVIEW;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; COST-BENEFIT ANALYSIS; HEPATITIS B; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; KIDNEY NEOPLASMS; LEUKEMIA, HAIRY CELL; LEUKEMIA, MYELOID, CHRONIC; LYMPHOMA, NON-HODGKIN; MULTIPLE MYELOMA; SARCOMA, KAPOSI;

EID: 0031557772     PISSN: 00071064     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Allan NC, Richards SM, Sheperd PC (1995) UK Medical Research Council randomised, multicentre trial of interferon-alpha nl for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council s Working Parties for Therapeutic Trials in Adult Leukaemia. Lancet 345: 1392-7
2. Cirelli R, Tyring SK (1995) Major therapeutic uses of interferons. Clin Immttnother 3: 27-87
3. Haria M, Benfield P (1995) Interferon a-2a: a review of its pharmacological properties and therapeutic use in the management of viral Hepatitis. Drugs 50: 873-96
4. Isaacs A, Lindeman J (1957) Virus interference: I. The interferon. Proc R Soc Land 147: 258-67
5. Italian Cooperative Study Group on Chronic Myeloid Leukaemia (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukaemia. N EnglJ Med 330: 820-5
6. Mandelli F, Avvisati G, Amadori S et al (1990) Maintenance treatment with recombinant Interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy. N EnglJ Med 322: 1430-4
7. Quesada JR, Hersh EM, Manning] et al (1986) Treatment of hairy cell leukemia with recombinant alpha-interferon. Blood 68: 493-7
8. Smalley RV, Andersen JW, Hawkins MJ et al (1992) Interferon combined with cytotoxic therapy for patients with non-Hodgkin's lymphoma. N Engt ] Med 327: 1336-41
9. Solal-Celigny P, Lepage E, Brousse N et al (1993) Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. N EnglJ Med 329: 1608-14
10. Vial T, Descotes J (1994) Clinical toxicity of interferons. Drug Safety 10: 115-50